கூடு உயிர் முயற்சிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கூடு உயிர் முயற்சிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கூடு உயிர் முயற்சிகள் Today - Breaking & Trending Today

China Digest: Oral care brand NYSCPS raises $62m; Sherpa leads $30m round in PAQ


China Digest: Oral care brand NYSCPS raises $62m; Sherpa leads $30m round in PAQ
July 20, 2021
Chinese oral care brand NYSCPS has raised nearly $62 million led by Huaxing Growth Capital. In a separate development, Sherpa Healthcare Partners has led a $30-million Series A round in the US-based biotech firm PAQ Therapeutics.
Huaxing Growth Capital invests in oral care brand NYSCPS
Huaxing Growth Capital, a flagship investment arm of investment bank China Renaissance, has led a 400-million-yuan ($61.6 million) Series B round in Chinese oral care brand NYSCPS, the investor announced on Monday.
Chinese investment companies Jinding Capital, CoStone Capital, and ABC Capital, which is affiliated with industry investment firm ABC Group, also participated in the round. Existing investors Sinovation Ventures, a venture firm led by ex-Google China head Kai-Fu Lee, and TikTok-owner ByteDance continued to back the Series B round. ....

United States , Cheng Xing , Kai Fu Lee , Ventures Fund , Huaxing Growth , Sherpa Healthcare Partners , Growth Capital , China Renaissance , Jinding Capital , Costone Capital , Sinovation Ventures , Google China , Tiktok Owner Bytedance , Crystal Stream Capital , Plum Ventures , Hong Kong Listed China Renaissance , Huaxing Growth Capital , Huaxing Healthcare Capital , Healthcare Partners , Huagai Capital , Nest Bio Ventures , Matrix Partners China , ஒன்றுபட்டது மாநிலங்களில் , செங் க்ஷிங் , கை ஃபூ லீ , முயற்சிகள் நிதி ,

PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation


Share this article
Share this article
CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/  PAQ Therapeutics, a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, today announced the completion of its $30 million Series A financing. PAQ s approach and technology expands the therapeutic potential of autophagy - the body s most versatile mechanism for natural cellular degradation – to target not only disease-causing proteins but lipids, pathogens and other substrates with the goal of restoring health. Sherpa Healthcare Partners led the Series A financing with participation from Huagai Capital, MSA Capital, and MRL Ventures Fund, joined by seed investors, Nest.Bio Ventures and Matrix Partners China. ....

United Kingdom , United States , Cheng Xing , Dee Glen , David Rubinsztein , Boxun Lu , Jin Quan Yu , Huaixiang Hao , Jared Rutter , Scripps Research Institute , Cancer Research , University Of Cambridge , Fudan University , United Kingdom Dementia Research Institute Group Leader , University Of Utah , Ventures Fund , Healthcare Partners , Huagai Capital , Nest Bio Ventures , Matrix Partners , Molecular Neurogenetics , Distinguished Professor , Ida Smith Endowed Chair , Bertha Hupp Professor , Scripps Research , Managing Partner ,